Document is current
Any future updates will be listed below
-
Authors
Coulombe, Patrick https://orcid.org/0009-0001-6959-8560
Tomellini, Elisa
Chagraoui, Jalila
Mayotte, Nadine
Sauvageau, Guy https://orcid.org/0000-0002-4333-7266
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-178113, FDN-143286)
Stem Cell Network (HZN-C4R1-1)
- License Information
-
More Information
Article History
Received: 17 April 2024
Accepted: 5 December 2024
First Online: 2 January 2025
Competing interests
: Except for G.S., the authors declare no competing interests. G.S. is co-founder of ExCellThera, a small biotech which owns an exclusive license to UM171.
